Log in

IPSEN S A/S Stock Price, News & Analysis (OTCMKTS:IPSEY)

-0.48 (-1.78 %)
(As of 10/20/2019 04:00 PM ET)
Today's Range
Now: $26.47
50-Day Range
MA: $24.63
52-Week Range
Now: $26.47
Volume1,450 shs
Average Volume496 shs
Market Capitalization$8.87 billion
P/E Ratio15.21
Dividend Yield0.75%
Ipsen SA operates as a pharmaceutical company worldwide. It operates in two segments, Specialty Care and Consumer Healthcare. The company offers drugs in oncology, endocrinology, neurology, gastroenterology, cognitive disorders, and rheumatology areas. Its products include Somatuline, which is an injectable treatment for acromegaly and neuroendocrine tumors; Cabometyx, a tablet formulation of cabozantinib for renal cell carcinoma; Onivyde for metastatic pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, and female sterility; and Dysport for motor disorders and muscular spasticity. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances



Sales & Book Value

Annual Sales$2.76 billion
Cash Flow$2.19 per share
Book Value$6.50 per share



Market Cap$8.87 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive IPSEY News and Ratings via Email

Sign-up to receive the latest news and ratings for IPSEY and its competitors with MarketBeat's FREE daily newsletter.

IPSEN S A/S (OTCMKTS:IPSEY) Frequently Asked Questions

What is IPSEN S A/S's stock symbol?

IPSEN S A/S trades on the OTCMKTS under the ticker symbol "IPSEY."

What is the consensus analysts' recommendation for IPSEN S A/S?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IPSEN S A/S in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for IPSEN S A/S.

Has IPSEN S A/S been receiving favorable news coverage?

Press coverage about IPSEY stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. IPSEN S A/S earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for IPSEN S A/S.

Who are some of IPSEN S A/S's key competitors?

What other stocks do shareholders of IPSEN S A/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IPSEN S A/S investors own include Bayerische Motoren Werke (BMW), ENI (ENI), Bayer (BAYN), Deutsche Bank (DBK), Siemens (SIE), Aeglea Bio Therapeutics (AGLE), Applied Genetic Technologies (AGTC), Heat Biologics (HTBX), Medivation (MDVN) and Nektar Therapeutics (NKTR).

Who are IPSEN S A/S's key executives?

IPSEN S A/S's management team includes the folowing people:
  • Mr. David D. Meek, CEO & Director (Age 56)
  • Mr. Aymeric Le Chatelier, Exec. VP & CFO (Age 50)
  • Dr. Aidan Murphy, Exec. VP of Technical Operations (Age 53)
  • Dr. Alexandre P. Lebeaut, Exec. VP of R&D and Chief Scientific Officer (Age 62)
  • Ms. Eugenia Litz, VP of Investor Relations

How do I buy shares of IPSEN S A/S?

Shares of IPSEY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is IPSEN S A/S's stock price today?

One share of IPSEY stock can currently be purchased for approximately $26.47.

How big of a company is IPSEN S A/S?

IPSEN S A/S has a market capitalization of $8.87 billion and generates $2.76 billion in revenue each year. The company earns $460 million in net income (profit) each year or $1.74 on an earnings per share basis. IPSEN S A/S employs 5,700 workers across the globe.View Additional Information About IPSEN S A/S.

What is IPSEN S A/S's official website?

The official website for IPSEN S A/S is http://www.ipsen.com/.

How can I contact IPSEN S A/S?

IPSEN S A/S's mailing address is 65 quai Georges Gorse, Boulogne-Billancourt cedex I0, 92650. The company can be reached via phone at 33-01-58-33-50-00 or via email at [email protected]

MarketBeat Community Rating for IPSEN S A/S (OTCMKTS IPSEY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  153 (Vote Outperform)
Underperform Votes:  167 (Vote Underperform)
Total Votes:  320
MarketBeat's community ratings are surveys of what our community members think about IPSEN S A/S and other stocks. Vote "Outperform" if you believe IPSEY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPSEY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel